Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Prevalence of the Antiphospholipid Antibodies in Young Adults with Ischemic Stroke

Antonella Vaccarino, MD, Maria Pagliaro, MD, Clara Rollone, Student, Fabio Melis, MD, Federica De Marco, MD, Katia Savio, MD, Marilena Guido, MD, Mario Bazzan, MD, Daniele Imperiale, MD, Massimo Pini, MD

Blood (2019) 134 (Supplement_1): 4952.

https://doi.org/10.1182/blood-2019-123727

Published: 2019

Journal Articles

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Blood (2008) 111 (8): 4004–4013.

https://doi.org/10.1182/blood-2007-10-116749

Published: 2008

Journal Articles

Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (Fl): Updated Results Suggest the Use of R-HDS as Salvage Treatment.

Blood (2007) 110 (11): 20.

https://doi.org/10.1182/blood.V110.11.20.20

Published: 2007

Journal Articles

Clinical and Molecular Results of the Multicenter Randomized GITMO-IIL Trial in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Rituximab-Supplemented High-Dose Sequential Chemotherapy (R-HDS) Is Superior to CHOP-R in Molecular Remissions Rate, EFS and PFS.

Blood (2006) 108 (11): 325.

https://doi.org/10.1182/blood.V108.11.325.325

Published: 2006

Journal Articles

Array-Based Comparative Genomic Hybridization (Array-CGH) in Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL): Recurrent Imbalances within a Highly Heterogeneous Background of Genomic Disruption.

Daniela Drandi, Marco Ladetto, Sonia Vallet, Loredana Santo, Irene Ricca, Maria Dell’Aquila, Luigia Monitillo, Monica Astolfi, Marina Ruggeri, Maria Teresa Ambrosini, Federica De Marco, Lydia Marino, Barbara Mantoan, Gloria Pagliano, Paola Omedè, Antonio Palumbo, Mario Boccadoro.

Blood (2005) 106 (11): 5088.

https://doi.org/10.1182/blood.V106.11.5088.5088

Published: 2005

Journal Articles

Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients.

Irene Ricca, MD, Alberto Rocci, MD, Daniela Drandi, PhD, Mara Compagno, PhD, Roberto Francese, PhD, Paola Omedè, PhD, Loredana Santo, MD, Michela Rosace, PhD, Federica De Marco, MD, Monica Astolfi, PhD, Chiara Lobetti Bodoni, MD, Maria Dell’Aquila, PhD, Sonia Vallet, MD, Luciana Bergui, MD, Andrea Gallamini, MD, Carlo Marinone, MD, Mario Boccadoro, MD, Corrado Tarella, MD, Marco Ladetto, MD

Blood (2005) 106 (11): 2104.

https://doi.org/10.1182/blood.V106.11.2104.2104

Published: 2005

Journal Articles

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome

Blood (2005) 105 (12): 4784–4791.

https://doi.org/10.1182/blood-2004-11-4201

Published: 2005

Journal Articles

Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL).

Marco Ladetto, MD, Barbara Mantoan, PhD, Federica De Marco, MD, Berardino Pollio, MD, Daniela Drandi, PhD, Irene Ricca, MD, Sonia Vallet, MD, Mara Compagno, PhD, Monica Astolfi, PhD, Maria Dell’Aquila, PhD, Roberto Francese, PhD, Gloria Pagliano, PhD, Luigia Monitillo, PhD, Giacomo Tamponi, MD, Mario Boccadoro, MD, Corrado Tarella, MD

Blood (2004) 104 (11): 1373.

https://doi.org/10.1182/blood.V104.11.1373.1373

Published: 2004

Journal Articles

Telomere Length of Hematopoietic Cells in Long-Term Post-Autograft Survivors: No Evidence of Accelerated Replicative Cell Senescence Despite the Persistent Reduction of Both Committed and Immature Progenitor Cell Compartments.

Alberto Rocci, MD, Irene Ricca, MD, Chiara Della Casa, MD, Paolo Longoni, PhD, Mara Compagno, PhD, Maurizio Battistelli, PhD, Roberto Francese, PhD, Federica De Marco, MD, Daniele Caracciolo, MD, Mario Boccadoro, MD, Dario Ferrero, MD, Marco Ladetto, MD, Carmelo Carlo-Stella, MD, Corrado Tarella, MD

Blood (2004) 104 (11): 4123.

https://doi.org/10.1182/blood.V104.11.4123.4123

Published: 2004

Journal Articles

Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines.

Marco Ladetto, MD, Irene Ricca, MD, Mara Compagno, PhD, Dario Ferrero, MD, Alberto Rocci, MD, Maria Dell’Aquila, PhD, Paola Omedè, PhD, Roberto Francese, PhD, Federica De Marco, MD, Sonia Vallet, MD, Loredana Santo, MD, Daniela Drandi, PhD, Monica Astolfi, PhD, Mario Boccadoro, MD, Corrado Tarella, MD

Blood (2004) 104 (11): 3389.

https://doi.org/10.1182/blood.V104.11.3389.3389

Published: 2004

Journal Articles

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders

Marco Ladetto, Mara Compagno, Irene Ricca, Marco Pagano, Alberto Rocci, Monica Astolfi, Daniela Drandi, Paola Francia di Celle, Maria Dell'Aquila, Barbara Mantoan, Sonia Vallet, Gloria Pagliano, Federica De Marco, Roberto Francese, Loredana Santo, Alessandra Cuttica, Carlo Marinone, Mario Boccadoro, Corrado Tarella

Blood (2004) 103 (12): 4644–4649.

https://doi.org/10.1182/blood-2003-12-4412

Published: 2004

NARROW

Prevalence of the Antiphospholipid Antibodies in Young Adults with Ischemic Stroke

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (Fl): Updated Results Suggest the Use of R-HDS as Salvage Treatment.

Clinical and Molecular Results of the Multicenter Randomized GITMO-IIL Trial in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Rituximab-Supplemented High-Dose Sequential Chemotherapy (R-HDS) Is Superior to CHOP-R in Molecular Remissions Rate, EFS and PFS.

Array-Based Comparative Genomic Hybridization (Array-CGH) in Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL): Recurrent Imbalances within a Highly Heterogeneous Background of Genomic Disruption.

Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients.

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome

Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL).

Telomere Length of Hematopoietic Cells in Long-Term Post-Autograft Survivors: No Evidence of Accelerated Replicative Cell Senescence Despite the Persistent Reduction of Both Committed and Immature Progenitor Cell Compartments.

Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines.

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only